Vorsitz/Chair: Björn Müller-Edenborn (Freiburg im Breisgau), Vanessa Rubesch-Kütemeyer (Detmold)
Agenda
08:30
(V1461)
Improvement of heart failure status and rhythm outcomes after catheter ablation for persistent atrial fibrillation in heart failure with preserved, mildly reduced and reduced ejection fraction
M.-A. Popa (München)
Zum Abstract
08:37
Diskussion
08:41
(V1462)
Predictors of Early Catheter Ablation Following Hospital Admission for Heart Failure and Atrial Fibrillation: Insights from a Seven-Year Cohort Study
T. Harloff (Hamburg)
Zum Abstract
08:48
Diskussion
08:52
(V1463)
Prediction of improvement in mitral and tricuspid regurgitation in patients with atrial fibrillation after restoration of sinus rhythm
F. Schwarz (Berlin)
Zum Abstract
08:59
Diskussion
09:03
(V1464)
Improvement in mitral and tricuspid regurgitation in patients with atrial fibrillation after restoration of sinus rhythm – A prospective cohort study
F. Schwarz (Berlin)
Zum Abstract
09:10
Diskussion
09:14
(V1465)
Effects of catheter ablation of atrial arrhythmias on LV function and mitral regurgitation
N. Tsianakas (Gießen)
Zum Abstract
09:21
Diskussion
09:25
(V1466)
Novel protein score predicts atrial fibrillation and clinical outcome in heart failure
M. T. Huttelmaier (Würzburg)
Zum Abstract
09:32
Diskussion
09:36
(V1467)
Inflammation has a major impact on LVEF recovery in Tachycardiomyopathy - results from the EMPATHY study
D. Heinzmann (Tübingen)
Zum Abstract
09:43
Diskussion
09:47
(V1468)
Prevalence of AF-mediated cardiomyopathy in consecutive patients admitted for cardioversion